HomeProductsBioactive CompoundsPI3K/Akt/mTOR PathwayPI3KSeletalisib
Chemical structure of CAS 1362850-20-1

Seletalisib

In Stock•Starting at $27 for 1 mg•Purity ≥ 98%
CAS No.1362850-20-1
MDL No.N/A
MFC23H14ClF3N6O
MW482.80
InChI KeyLNLJHGXOFYUARS-OAQYLSRUSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98+%$27In Stock
2 mg98+%$40In Stock
5 mg98+%$62In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1362850-20-1
Product NameSeletalisib

Biological Targets

PIK3CD

Associated Conditions

Sjogren syndrome·psoriasis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K.

The Journal of pharmacology and experimental therapeutics • Vol. 361, Issue 3 • 2017
PMID: 28442583DOI: 10.1124/jpet.116.237347

First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases.

European journal of clinical pharmacology • Vol. 73, Issue 5 • 2017
PMID: 28160012PMC: PMC5384962DOI: 10.1007/s00228-017-2205-7

Acetyl coenzyme A carbosylase. Circular dichroism studies of Escherichia coli biotin carboxyl carrier protein.

The Journal of biological chemistry • Vol. 251, Issue 7 • 1976
PMID: 5438

Documentation